Royal Bank of Canada »

Theriva Biologics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Theriva Biologics (TOVX) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Theriva Biologics

Tip: Access up to 7 years of quarterly data

All positions including Theriva Biologics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theriva Biologics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2026-03-31 $0 1 0.00

More positions owned by Royal Bank of Canada

Apple (AAPL)
NVIDIA Corporation (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Bank Of Montreal Cadcom (BMO)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Cibc Cad (CM)
Canadian Natural Resources (CNQ)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Royal Bank of Canada

Top funds holding Theriva Biologics

Geode Capital Management
Vanguard Group
Virtu Financial
Vanguard Fiduciary Trust
UBS Group
Vanguard Capital Management
Jane Street
Ikarian Capital
Two Sigma Securities
XTX Topco
Boothbay Fund Management
Morgan Stanley
Intl Fcstone
Two Sigma Investments
Schwarz Dygos Wheeler Investment Advisors

View all funds holding Theriva Biologics